The initial reporter stated that they received discrepant results for a total of 9 patient samples tested with the elecsys tsh assay, elecsys ft3 iii, and the elecsys ft4 iii assay on a cobas 8000 e 801 module.It was asked, but it is not known if any incorrect results were reported outside of the laboratory.This medwatch will apply to the ft4 assay.Please refer to the medwatch with patient identifier (b)(6) for information related to the tsh assay and refer to the medwatch with patient identifier (b)(6) for information related to the ft3 assay.The samples were initially tested on this customer's e801 analyzer on (b)(6) 2019.The samples were repeated on a centaur analyzer.The samples were provided for investigation where they were tested on a cobas 8000 e 602 module on (b)(6) 2019.For investigation, the samples were also tested on a second e801 analyzer and a cobas e 411 immunoassay analyzer on (b)(6) 2019.No adverse events were alleged to have occurred with the patients.The serial number of the e602 analyzer used for investigation is (b)(4).Ft4 reagent lot number 391521, with an expiration date of 29-feb-2020 was used on this analyzer.The serial number of the e801 analyzer used for investigation is (b)(4).Ft4 reagent lot number 380330, with an expiration date of 31-dec-2019 was used on this analyzer.The serial number of the e411 analyzer used for investigation is (b)(4).Ft4 reagent lot number 391521, with an expiration date of 29-feb-2020 was used on this analyzer.
|
Two patient samples,(b)(6) and (b)(6) were returned for investigation.The investigation did not identify a product problem.Due to differences in the setups of the assays, the different antibodies used and differences in the overall standardization materials and methodologies, mathematically different values can be generated.This needs to be considered when interpreting the values of this patient.
|